Grazax provides sustained disease control in patients with grass pollen allergy

A US federal jury has ruled that Abbott is to pay Johnson & Johnson $1.67bn for infringing a patent

Roche plans to drop its membership of the Pharmaceutical Research and Manufacturers Association in the US

Bayer Schering Pharma AG, Germany, has entered into an exclusive licence agreement with US biotech company Celera Corporation

French drug maker sanofi-aventis is being adversely affected by questions over the safety of its key diabetes product, Lantus

Australian scientists have developed a therapy that promises to destroy drug resistant cancer cells

A phase I clinical trial of a new cancer treatment has produced promising results

French firm sanofi-aventis will announce plans to restructure its R&D business within weeks

Cancer survival rates in the over-75s in the UK are worsening, despite improvements in care standards, say researchers

GSK and Chroma Therapeutics will collaborate to develop macrophage-targeted compounds

Treating respiratory illnesses with antibiotics should be standardised across Europe, according to experts

Comments are being invited by the European Medicines Agency on its draft transparency policy, up to September 25, 2009

Biogen Idec is to start a phase III trial to evaluate the efficacy and safety of PEGylated Interferon beta-1a in patients with relapsing multiple sclerosis

New research suggests a link between smoking and brain damage, according to a recent report published in the Journal of Neurochemistry

The US FTC has requested that Merck & Co and Schering-Plough must provide additional information regarding their $41.1bn merger

Changes in the levels of the neurotransmitter dopamine may explain brain grey matter reductions experienced by patients with fibromyalgia, a study has found

In 2002, only 53 per cent of patients with osteosarcoma were alive five years after diagnosis, showing no improvement on survival rates in 1981

Roche has entered into a collaboration agreement with Covagen, a Swiss biotechnology company

Biotech products will account for the top six biggest selling drugs globally by 2014, according to a new report

US-based Watson Pharmaceuticals has entered into a $1.75bn cash and stock deal to acquire privately held Arrow Group